Bharat Immunological & Biological Corporation Share Price

Corporate Action

CMP as on10-Aug-22 15:29

₹ 26.60
0.4 1.53%

Open

₹ 26.40

Turnover (lac)

₹ 25

Prev. Close

₹ 26.20

Day's Vol (shares)

₹ 18,531

Day's Range

₹ 26.10
₹ 27.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Aug-2022 - -
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 11th August 2022 to approve the financial results of the Company for the quarter ended 30th June 2022.
Board Meeting - 18-May-2022 - -
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 30th May 2022 to approve the accounts of the Company for the quarter and year ended 31st March 2022.
Board Meeting - 31-Jan-2022 - -
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 8th February 2022 to approve the accounts of the Company for the quarter ended 31st December 2021. In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in its Meeting on 08.02.2022. The XBRL filing will be made succeeding to this. (As per BSE Announcement Dated on 09/02/2022)
Board Meeting - 22-Oct-2021 - -
Quarterly Results In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2021 approved by the Board of the Company in its Meeting on 29.10.2021. (As per BSE Announcement Dated on 30/10/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity